16537846

Source:http://linkedlifedata.com/resource/pubmed/id/16537846

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0020449, umls-concept:C0024117, umls-concept:C0028778, umls-concept:C0030705, umls-concept:C0035253, umls-concept:C0060657, umls-concept:C0213771, umls-concept:C1280500
pubmed:issue	3
pubmed:dateCreated	2006-3-15
pubmed:abstractText	The combination of short-acting beta(2)-agonists and anticholinergics in the treatment of COPD has been well documented, but data on combination of long-acting agents are lacking.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16537846-16537841, http://linkedlifedata.com/resource/pubmed/commentcorrection/16537846-16944859
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0231335
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Bronchodilator Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cholinergic Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Ethanolamines, http://linkedlifedata.com/resource/pubmed/chemical/Scopolamine Derivatives, http://linkedlifedata.com/resource/pubmed/chemical/formoterol, http://linkedlifedata.com/resource/pubmed/chemical/tiotropium
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0012-3692
pubmed:author	pubmed-author:AumannJoseph LJL, pubmed-author:CornelissenPiet J GPJ, pubmed-author:JanssensEduardE, pubmed-author:MuellerAchimA, pubmed-author:SmeetsJoseph JJJ, pubmed-author:VerhaertJanJ, pubmed-author:van NoordJan AJA
pubmed:issnType	Print
pubmed:volume	129
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	509-17
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:16537846-Adrenergic beta-Agonists, pubmed-meshheading:16537846-Aged, pubmed-meshheading:16537846-Bronchodilator Agents, pubmed-meshheading:16537846-Cholinergic Antagonists, pubmed-meshheading:16537846-Circadian Rhythm, pubmed-meshheading:16537846-Cross-Over Studies, pubmed-meshheading:16537846-Drug Therapy, Combination, pubmed-meshheading:16537846-Ethanolamines, pubmed-meshheading:16537846-Female, pubmed-meshheading:16537846-Forced Expiratory Volume, pubmed-meshheading:16537846-Humans, pubmed-meshheading:16537846-Male, pubmed-meshheading:16537846-Middle Aged, pubmed-meshheading:16537846-Pulmonary Disease, Chronic Obstructive, pubmed-meshheading:16537846-Scopolamine Derivatives, pubmed-meshheading:16537846-Spirometry, pubmed-meshheading:16537846-Treatment Outcome, pubmed-meshheading:16537846-Vital Capacity
pubmed:year	2006
pubmed:articleTitle	Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD.
pubmed:affiliation	Department of Respiratory Diseases, Atrium medisch centrum, Henri Dunantstraat 5, 6419 PC Heerlen, the Netherlands. j.a.vannoord@atriummc.nl
pubmed:publicationType	Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study